Keyphrases
Infected Patients
100%
Soluble Urokinase Plasminogen Activator Receptor (suPAR)
100%
Whole Blood Culture
100%
Human Immunodeficiency Virus Type 1 (HIV-1)
100%
Human Immunodeficiency Virus Patients
21%
Immune Activation
7%
Blood Levels
7%
Leukocytes
7%
Human Immunodeficiency Virus Infection
7%
Enzyme-linked Immunosorbent Assay (ELISA)
3%
Two-component Domains
3%
Receptor Subtypes
3%
Leukocyte Subsets
3%
Time-resolved Fluorescence Immunoassay (TRFIA)
3%
Phytohemagglutinin
3%
Urokinase-type Plasminogen Activator
3%
Receptor II
3%
Lipopolysaccharide
3%
Plasma Parameters
3%
Soluble Form
3%
Immunology and Microbiology
Urokinase Receptor
100%
Human Immunodeficiency Virus 1
100%
Human immunodeficiency virus
42%
Leukocyte
21%
Blood Level
21%
Immunity
14%
Human Immunodeficiency Virus Infection
14%
Phytohaemagglutinin
7%
Immunoassay
7%
Enzyme-Linked Immunosorbent Assay
7%